Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

(2011) Richard Furie et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

(2011) Sandra V Navarra et al.   LANCET

Infections in systemic lupus erythematosus

(2010) SV Navarra et al.   LUPUS

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

(2009) Daniel J. Wallace et al.   ARTHRITIS AND RHEUMATISM

Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus

(2009) Elizabeth A. Bachen et al.   ARTHRITIS AND RHEUMATISM

Malignancies in systemic lupus erythematosus

(2009) Emese Kiss et al.   AUTOIMMUNITY REVIEWS

The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus

(2009) Michael P. Cancro et al.   JOURNAL OF CLINICAL INVESTIGATION

Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus

(2008) Michelle Petri et al.   ARTHRITIS AND RHEUMATISM

Two aspects of the clinical and humanistic burden of systemic lupus erythematosus: Mortality risk and quality of life early in the course of disease

(2008) Robert Campbell et al.   ARTHRITIS AND RHEUMATISM

Accumulation of coronary artery disease risk factors over three years: Data from an international inception cohort

(2008) M. B. Urowitz et al.   ARTHRITIS AND RHEUMATISM

Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California

(2008) Arti Parikh-Patel et al.   CANCER CAUSES & CONTROL

Systemic Lupus Erythematosus

(2008) Anisur Rahman et al.   NEW ENGLAND JOURNAL OF MEDICINE